Decoy Therapeutics Inc. (DCOY) insider trading.
In Q3 2026, insiders at Decoy Therapeutics Inc. reported 10 non-derivative transactions on 11 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.
- Transactions
- 10
- Purchases (P)
- 0
- Sales (S)
- 0
- Net shares, P minus S
- 0
- Insiders
- 10
- Last filed
- 2026-09-02
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Lieber Jonathan I | Director | 1 | 0 | 0 |
| Pierce Frederick II | Officer · Chief Executive Officer | 1 | 0 | 0 |
| Hanish Arnold C | Director | 1 | 0 | 0 |
| Rosenblum Mark J | Officer · Chief Financial Officer | 1 | 0 | 0 |
| Lammers Paul | Director | 1 | 0 | 0 |
| McVicar William K. | Director | 1 | 0 | 0 |
| Burleson Tess | Director | 1 | 0 | 0 |
| Hibner Barbara Louise | Officer · Chief Scientific Officer | 1 | 0 | 0 |
| Marschel Peter Klaus | Officer · Chief Business Officer | 1 | 0 | 0 |
| Gauthier Patricia G. | Director | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-31 | Lieber Jonathan I | A (A) | 2,000 | $0 | 2,002 | Form 4 |
| 2026-08-31 | Pierce Frederick II | A (A) | 33,455 | $0 | 34,844 | Form 4 |
| 2026-08-31 | Hanish Arnold C | A (A) | 3,000 | $0 | 3,418 | Form 4 |
| 2026-08-31 | Rosenblum Mark J | A (A) | 9,682 | $0 | 11,363 | Form 4 |
| 2026-08-31 | Lammers Paul | A (A) | 2,000 | $0 | 2,001 | Form 4 |
| 2026-08-31 | McVicar William K. | A (A) | 3,000 | $0 | 3,002 | Form 4 |
| 2026-08-31 | Burleson Tess | A (A) | 2,000 | $0 | 2,002 | Form 4 |
| 2026-08-31 | Hibner Barbara Louise | A (A) | 4,216 | $0 | 4,216 | Form 4 |
| 2026-08-31 | Marschel Peter Klaus | A (A) | 3,900 | $0 | 3,900 | Form 4 |
| 2026-08-31 | Gauthier Patricia G. | A (A) | 2,000 | $0 | 2,000 | Form 4 |
Transaction codes in this quarter
Get DCOY insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1615219&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · DCOY company page · Decoy Therapeutics Inc. on SEC.gov
Questions
Are insiders buying or selling Decoy Therapeutics Inc. (DCOY)?
In Q3 2026, insiders at Decoy Therapeutics Inc. reported 10 non-derivative transactions on 11 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Decoy Therapeutics Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/dcoy.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.